CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA
about
Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic studyUtility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEASerum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer.Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis.Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer.Advances in biomarker research for pancreatic cancer.Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.Identification of cystatin SN as a novel biomarker for pancreatic cancer.Comparative study of CA242 and CA19-9 in chronic pancreatitis.Novel tumour markers: a diagnostic role in pancreatic cancer?Preoperative serum levels of CEA and CA 242 in colorectal cancer.Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis.Normalisation of high CA 19-9 values in autoimmune hepatitis after steroidal treatment.Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases.Evaluation of the analytical and clinical performances of time-resolved fluoroimmunoassay for detecting carcinoma antigen 50.
P2860
Q28270259-FB96102A-D968-4878-91B3-51FFBDFC6EE6Q34544953-D4E46E62-E43D-497F-81D6-9098E97760FEQ35089502-F72C5E15-8858-4B67-B9EB-DF1F91B2A8AFQ35375731-504F08B4-48BB-4646-B103-548D5BA79472Q35517344-4EE0D355-6B4D-4946-AAAA-E58BFDD4BBCCQ36126609-D622CDA6-3FBD-4017-AB2A-6D0E75BDCAA5Q37824829-0F4E72A3-AC3B-42E1-B2FC-C4CF72EE603FQ38921259-DCC3FE17-C1EB-487F-98B4-329BF28C9287Q39993160-A5A7E2ED-16F2-4CBF-8F4D-F7C2C9F878C1Q42590199-97AB0061-E5DF-4CCB-AA29-C61D69025216Q42590533-CB3A1233-56EE-4D18-993B-8FBCCA5AEA60Q45404222-49AD9B2E-A954-438E-A09D-236451789B04Q46705041-C81BCBB5-1D43-4F6A-8F3D-BA67038858BFQ51549059-26B30DA4-1E37-462C-965A-E59E5F0432C9Q53513501-5485A70D-60F1-408A-BF38-4B9D38C5B8A8
P2860
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA
description
1994 nî lūn-bûn
@nan
1994 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
CA 242, a new tumour marker fo ...... on with CA 19-9, CA 50 and CEA
@ast
CA 242, a new tumour marker fo ...... on with CA 19-9, CA 50 and CEA
@en
CA 242, a new tumour marker fo ...... on with CA 19-9, CA 50 and CEA
@nl
type
label
CA 242, a new tumour marker fo ...... on with CA 19-9, CA 50 and CEA
@ast
CA 242, a new tumour marker fo ...... on with CA 19-9, CA 50 and CEA
@en
CA 242, a new tumour marker fo ...... on with CA 19-9, CA 50 and CEA
@nl
prefLabel
CA 242, a new tumour marker fo ...... on with CA 19-9, CA 50 and CEA
@ast
CA 242, a new tumour marker fo ...... on with CA 19-9, CA 50 and CEA
@en
CA 242, a new tumour marker fo ...... on with CA 19-9, CA 50 and CEA
@nl
P2093
P2860
P356
P1476
CA 242, a new tumour marker fo ...... on with CA 19-9, CA 50 and CEA
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1994.332
P407
P50
P577
1994-09-01T00:00:00Z
P5875
P6179
1012656376